Dilated cardiomyopathy

4 trials 3 recruiting MedDRA PT
4 Registered trials
3 Recruiting
4 Unique sponsors
3 Unique IMPs
2 Commercial trials
Drug classes (ATC)
— ATC code not specified 4
M Musculoskeletal (ATC M) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 3 substances
Phase II/III: 1 Phase II: 3 Phase I: 1

Filter these 4 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 4 trials

Phase II/III

1 trial
  • Kardigan Inc. Commercial
    DANICAMTIV
    2025-522553-19-00 9 countries 2026 n=240
    Recruiting

Phase II

3 trials
  • Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia Academic
    RISEDRONATE SODIUM
    2023-509431-29-00 1 country 2025 n=5
    Recruiting
  • Red Andaluza De Diseno Y Traslacion De Terapias Avanzadas Fundacion Publica Andaluza Progreso Y Salud Academic
    AUTOLOGOUS BONE MARROW-DERIVED ADULT MONONUCLEAR CELLS, NOT EXPANDED
    2024-516594-71-01 1 country 2013 n=51
    Ended
  • Red Andaluza De Diseno Y Traslacion De Terapias Avanzadas Fundacion Publica Andaluza Progreso Y Salud Academic
    AUTOLOGOUS BONE MARROW-DERIVED ADULT MONONUCLEAR CELLS, NOT EXPANDED
    2024-516594-71-01 1 country 2013 n=51
    Ended

Phase I

1 trial
  • AstraZeneca AB Commercial
    IMP not specified
    2025-522002-20-00 1 country 2025 n=36
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Red Andaluza De Diseno Y Traslacion De Terapias Avanzadas Fundacion Publica Andaluza Progreso Y Salud Academic 2 Phase II 0
AstraZeneca AB Commercial 1 Phase I 1
Kardigan Inc. Commercial 1 Phase II/III 1
Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia Academic 1 Phase II 1
New trials by year
2025
2
2026
1
← All indication landscapes